(Q54363389)

English

Activity of the pyrazoloacridines against multidrug-resistant tumor cells.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

Activity of the pyrazoloacridines against multidrug-resistant tumor cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

multiple drug resistance

1 reference

based on heuristic

inferred from title

author name string

J Sebolt

1

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

M Havlick

2

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

K Hamelehle

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

J Nelson

4

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

W Leopold

5

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

R Jackson

6

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

publication date

1 January 1989

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

24

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

4

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

219-224

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

https://scigraph.springernature.com/pub.10.1007/bf00257621

0 references

2-(aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental antitumor activity of aminoanthraquinones

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of cross-resistance profiles for new agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of aclacinomycin A in acute leukemia in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2752501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00257621

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2752501

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54363389&oldid=1381124965"